STERIS plc — News

While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-08-05 19:31:09

Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago.

zacks.com - 2026-08-05 19:11:44

DUBLIN, IRELAND, Aug. 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for the first quarter of fiscal 2027 increased 7% to $1.5 billion compared with $1.4 billion in the first quarter of fiscal 2026. Constant currency organic revenue growth was 6% in the first quarter.

globenewswire.com - 2026-08-05 16:30:00

Medical equipment maker Steris said on Wednesday it will invest $600 million to build a manufacturing ​and distribution hub in North Carolina for chemicals ‌used by healthcare and pharmaceutical customers.

reuters.com - 2026-08-05 09:27:25

• This Formulated Chemistries Center of Excellence will support sterilization and disinfection for the global Healthcare and Pharmaceutical industries

globenewswire.com - 2026-08-05 08:45:00

DUBLIN, IRELAND, July 30, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.69 per share. This represents a $0.06 increase in the dividend and the Company's 21st consecutive year of dividend growth. The dividend is payable on September 25, 2026, to shareholders of record at the close of business on September 4, 2026.

globenewswire.com - 2026-07-30 16:30:00

STE is expected to deliver fiscal first-quarter revenue and EPS growth, driven by strength in Healthcare, continued momentum in AST, and healthy demand in Life Sciences.

zacks.com - 2026-07-28 10:46:16

DUBLIN, IRELAND, July 27, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2027 first quarter results at 9:00 a.m. ET on August 6, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc.

globenewswire.com - 2026-07-27 16:30:00

Steris provides infection prevention products and sterilization services to medical clientele (such as hospitals, outpatient surgery centers, and pharmaceutical companies). Steris has increased its dividend for 21 consecutive years. The 10-year dividend growth rate of 9.6% is strong, but more recent dividend raises have actually been over 10%. STE has a great financial position. Its long-term debt/equity ratio is 0.3, while the interest coverage ratio is over 18.

seekingalpha.com - 2026-07-27 09:45:00

Entropy Technologies LP lessened its position in shares of STERIS plc (NYSE: STE) by 25.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,899 shares of the medical equipment provider's stock after selling 3,398 shares during the period. Entropy Technologies LP's holdings

defenseworld.net - 2026-07-27 04:04:04

Arrowstreet Capital Limited Partnership boosted its stake in shares of STERIS plc (NYSE: STE) by 20.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 519,511 shares of the medical equipment provider's stock after purchasing an additional 88,872 shares during

defenseworld.net - 2026-07-26 03:49:51

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

zacks.com - 2026-06-22 10:46:08

Steris (STE) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-10 12:31:04

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

zacks.com - 2026-06-09 10:51:07

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

zacks.com - 2026-06-03 10:45:32

STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.

zacks.com - 2026-05-22 13:15:21

STERIS NYSE: STE reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027.

marketbeat.com - 2026-05-15 06:12:00

STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.

zacks.com - 2026-05-12 15:25:17

STERIS plc (STE) Q4 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-12 13:30:48

Steris (STE) came out with quarterly earnings of $2.83 per share, missing the Zacks Consensus Estimate of $2.86 per share. This compares to earnings of $2.74 per share a year ago.

zacks.com - 2026-05-11 19:12:05

Medical equipment maker Steris forecast fiscal 2027 profit above Wall Street expectations ​on Monday, betting on strong demand ‌for its sterilization services despite narrowly missing estimates for fourth-quarter adjusted profit.

reuters.com - 2026-05-11 18:33:14

DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.

globenewswire.com - 2026-05-11 16:30:00

DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors. “We are pleased to welcome Pierre to our Board,” said Mohsen Sohi, Chairman of STERIS.

globenewswire.com - 2026-05-07 16:30:00